A former researcher at Nemours Children’s Health in Wilmington, Del., admitted to falsifying and incorrectly reporting data in at least two published studies, both of which were supported by grants from the National Institutes of Health.
One of the retracted papers, "Neointimal hyperplasia after carotid transection and anastomosis surgery is associated with degradation of decorin and platelet-derived growth factor signaling", appeared in JVS-Vascular Science in 2020. According to the retraction notice posted in October, Sampson contacted the journal and "admitted to manipulating samples and incorrectly reporting of data" to produce "the desired result". Her co-authors were unaware of her actions, according to the notice.
The other retracted paper, "Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma", appeared in Oncotarget in 2016. According to the retraction notice, Sampson "confirmed there was incorrect reporting of data" for seven figures in the paper, including polymerase chain reaction experiments without template controls. The notice also included a statement attributed to Sampson in which she accepted "sole responsibility for the errors and the incorrect reporting of data".
More: https://retractionwatch.com/2024/11/27/cancer-researcher-admitted-faking-data/
